ArticleSurgical endoscopy2025
Impact of articulating laparoscopic instrument-assisted gastrectomy with D2 lymphadenectomy on perioperative and oncologic outcomes compared with conventional laparoscopy: a propensity score matching analysis.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of the efficacy and safety of single-incision versus multi-port laparoscopic D2 lymphadenectomy for locally advanced gastric cancer: a systematic review and meta-analysis.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundArticulating laparoscopic instruments (ALIs) have been developed to overcome the limited dexterity afforded by conventional laparoscopic instruments (CLIs). This study aimed to compare the postoperative and oncologic outcomes of patients who underwent laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer using CLIs versus ALIs.
methodsThis retrospective study included 138 patients who underwent laparoscopic gastrectomy with D2 dissection for gastric cancer at a single institution from January 2018 to January 2024. Propensity score matching analysis was performed to minimize selection bias and compare surgical outcomes.
resultsAfter matching, 39 patients were included in each group. The ALI group showed significantly faster postoperative recovery, with a shorter hospital stay (4.0 [3.0-5.0] days vs. 5.0 [4.0-7.0] days, p = 0.001) and quicker time to first flatus (2.0 [2.0-3.0] days vs. 3.0 [2.0-3.0] days, p = 0.004). Although the ALI group had a shorter operative time and lower estimated blood loss, these differences were not statistically significant (p = 0.202 and p = 0.634, respectively). Complication rates, including major complications, were similar between the two groups. Long-term oncologic outcomes, including overall survival and recurrence-free survival, did not differ significantly between the groups (p = 0.622 and p = 0.756, respectively).
conclusionThe use of ALIs in laparoscopic gastrectomy with D2 lymphadenectomy was associated with improved short-term perioperative outcomes without compromising long-term oncologic safety. These findings suggest that ALIs may enhance surgical efficiency and postoperative recovery in gastric cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.